ORAI1 and breast carcinoma: Unlike 2-APB, LOCI directly affected ORAI1 and ORAI3 at an extracellular-facing site, rather than intervening in the STIM1–ORAI1 interaction, and blocked Ca2+ entry in Jurkat T cells and a metastatic breast cancer mouse model.